EligibleTrials

Clinical trials recruiting for Head and Neck Cancers Nasopharynx

Fewer than 3 recruiting trials found.

1
Recruiting trials
11
US states with sites
2
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 1 1Phase 2 1

Drugs and treatments being studied

InterventionTrials
VMD-928 100 mg Tablet1
VMD-928 Tablet and Pembrolizumab (200 mg)1

Where trials are recruiting (top US states)

StateRecruiting trials
California1
Connecticut1
District of Columbia1
Florida1
New Jersey1
New Mexico1
New York1
Ohio1
Pennsylvania1
Texas1
Utah1

Top cities

Albuquerque, New Mexico 1Englewood, New Jersey 1Florham Park, New Jersey 1Fort Lauderdale, Florida 1Hartford, Connecticut 1Houston, Texas 1Maumee, Ohio 1Morristown, New Jersey 1New York, New York 1Pembroke Pines, Florida 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Head and Neck Cancers Nasopharynx often also study these conditions. Each links to its own recruiting-trial list.

Small Cell Lung Cancer ( SCLC ) 29Pancreatic cancer 870Non-small cell lung cancer 507Mesothelioma 27Lung cancer 2180Head and Neck Squamous Cell Carcinoma HNSCC 11Head and Neck Squamous Cell Carcinoma 42Head and Neck Carcinoma 6Head and Neck Cancers 8Esophageal cancer 65

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Head and Neck Cancers Nasopharynx trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.